Patent · US Active

1,2,5-substituted benzimidazoles as FLAP modulators

US9265770B2 · kind B2 · utility

3Cited by

4References

11Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Wenying Chai · San Diego, US
Charlotte Pooley Deckhut · San Diego, US
Curt A. Dvorak · Poway, US
Wendy Eccles · San Diego, US
James P. Edwards · San Diego, US
Steven Goldberg · Encinitas, US
Paul J. Krawczuk · San Diego, US
Alec D. Lebsack · San Diego, US
Jing Liu · San Diego, US
Virginia M. Tanis · Carlsbad, US
Kyle T. Tarantino · Princeton, US

Key dates

Filing date	May 18, 2015
Grant date	Feb 23, 2016
Priority date	—
Expiry date	May 18, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of Formula (I),and solvates, hydrates, and pharmaceutically acceptable salts thereof, wherein ring A, R1, R5 and R6 are as defined herein, useful as FLAP modulators. The invention also relates to pharmaceutical compositions comprising compounds of Formula (I). Methods of making and using the compounds of Formula (I) are also within the scope of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.